Recombinant human coagulation factor VIIa N01 (Nanjing Chia-Tai Tianqing)

重组人凝血因子Ⅶa N01（正大天晴）

Report date: 2025/07/04 15:26:21

Base Information

Drug NameRecombinant human coagulation factor VIIa N01 (Nanjing Chia-Tai Tianqing)
Drug Alias Name重组人凝血因子Ⅶa N01（正大天晴）重组人凝血因子Ⅶa（正大天晴）TQG-203
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor IX stimulantsCoagulation factor X stimulantsBlood coagulation pathway activation +[4] 
TargetsCoagulation factor IXCoagulation factor X
Therapy Area/IndicationsHemophilia BHemophilia A
Global Approved IndicationsHemophilia BHemophilia A
Approved Indications in ChinaHemophilia BHemophilia A
Original Approved Country/TerritoryMainland China
Original Approved Date2025/06/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNanjing Zhengda Tianqing Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group
Inactive CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Active IndicationsHemophilia BHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A